Members of the genus *Brucella* are the infectious agents of brucellosis, a neglected disease responsible for economic losses resulting from abortion and low performance in production animals ([@R1]). The 4 species mainly responsible for this widespread bacterial zoonosis are *B. melitensis*, *B. abortus*, *B. suis*, and to a lesser extent *B. canis*. Underdiagnosis and limited awareness of the disease among healthcare practitioners is common in many countries ([@R1]).

*B. neotomae*, isolated in 1957 from wood rats (*Neotoma lepida*) in North America ([@R2]), has been considered nonzoonotic ([@R3]). It has been isolated from target organs of experimentally infected mice and guinea pigs ([@R4],[@R5]). We report the isolation of *B. neotomae* from cerebrospinal fluid samples from 2 human patients with neurobrucellosis.

The Study
=========

In 2008, a *Brucella* sp. isolate was submitted to the Tropical Diseases Research Center at the Universidad de Costa Rica. This isolate (denoted strain bneohCR2) was cultured from a cerebrospinal fluid sample obtained from a 64-year-old male patient at one of the main hospitals in San José, Costa Rica. In 2011, another isolate (denoted strain bneohCR1) was recovered from a cerebrospinal fluid sample from a 51-year-old male patient at a regional hospital in Costa Rica. As is common for other patients with brucellosis, the blood leukocyte count for each patient was almost within the reference range, and C-reactive protein level was within reference range. Both patients showed clinical signs compatible with neurobrucellosis ([@R6]), had positive Rose Bengal test results, and recovered after receiving 1 month of streptomycin (750 mg/d) and 3 months of doxycycline (100 mg/12 h).

Further bacteriologic analysis ([@R7],[@R8]) confirmed that the isolates were a *Brucella* sp. ([Table](#T1){ref-type="table"}). Real-time PCR high-resolution melting analysis ([@R9]) confirmed genus designation but was inconclusive regarding species designation. Bruce-ladder multiplex PCR ([@R10]) and multiple loci variable number of tandem repeats--16-loci panel analysis (<http://mlva.u-psud.fr/brucella/>[;]{.ul}[Figure 1](#F1){ref-type="fig"}) indicated that the profiles for both DNA isolates corresponded to profiles for *B. neotomae*. Analysis of bneohCR2 by multiplex single-nucleotide polymorphism (SNP) primer extension assay ([@R11]) and by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of protein extracts ([@R12]) ([Technical Appendix](#SD1){ref-type="local-data"} Table 1) confirmed that the isolate was *B. neotomae*.

###### Differential biochemical profile of *Brucella* isolates from 2 men with neurobrucellosis, Costa Rica, 2008 and 2011

  ---------------------------- ---------- ----------
  Analysis                     bneohCR1   bneohCR2
  Biochemical tests                       
  Oxidase                      \-         --
  Citrate utilization          --         --
  Nitrate reduction            \+         \+
  CO~2~ required               --         --
  H~2~S production             \+         \+
  Urease activity, h           0--0.5+    0--0.5+
  Growth in presence of dyes              
  Thionin 20 μg/mL             --         --
  Basic fuchsin 20 μg/mL       --         --
  A                            \+         \+
  M                            --         --
  ---------------------------- ---------- ----------

![Dendrogram based on multiple locus variable number of tandem repeats--16-loci panel analysis of *Brucella* spp. (<http://mlva.u-psud.fr/brucella/>) and clinical isolates from human cerebrospinal fluid samples from 2 patients with brucellosis. The isolates bneohCR1 and bneohCR2 (red branches) showed a pattern consistent with previously reported profiles for *Brucella neotomae* (blue shading). Black, gray, and tic marks are used to differentiate between adjacent species. Arrows separate small neighboring clusters and indicate the *B. neotomae* cluster.](16-2018-F1){#F1}

We performed whole-genome sequencing of bneohCR1 and bneohCR2 and resequencing of reference strain *B. neotomae* 5K33. Sequencing data were deposited at the European Nucleotide Archive (<http://www.ebi.ac.uk/ena/>) under accession codes ERS1563929 (bneohCR1), ERS1563928 (bneohCR2), and ERS162447 (5K33). To place the bneohCR1 and bneohCR2 in a phylogenetic context, publicly available reads from 51 *Brucella* whole-genome sequences ([Technical Appendix](#SD1){ref-type="local-data"} Table 2) were aligned and then mapped to *B. suis* 1330 by using SMALT version 0.5.8 (<ftp://ftp.sanger.ac.uk/pub/resources/software/smalt/>). Reads from bneohCR1 and bneohCR2 genomes mapped to 98.6% of the *B. suis* 1330 genome. SNPs were called from the alignment by use of Samtools (<http://samtools.sourceforge.net/>), and 34,307 variable sites across all isolates were extracted by using SNP sites ([@R13]). The resulting alignment of SNPs was used for maximum-likelihood phylogenetic reconstruction by use of RAxML version 7.0.4 (<https://github.com/stamatak/standard-RAxML>). The generated phylogenetic tree confirmed that the bneohCR isolates clustered together with *B. neotomae* reference strain 5K33 (ENA accession no. JMSC01, assembly accession no. GCA_00742255.1) ([Figure 2](#F2){ref-type="fig"}). Isolates bneohCR1 and bneohCR2 differed from the reference genome by 174 and 160 SNPs, respectively. This number of SNPs is smaller than that between *B. abortus* 9--941 and *B. abortus* 2308 (214 SNPs), which are 2 well-recognized strains of the same *Brucella* species.

![Phylogenetic tree based on 34,307 single-nucleotide polymorphisms (SNPs) found among 51 *Brucella* genome sequences. The clinical isolates bneohCR1 and bneohCR2 cluster with *B. neotomae* 5K33 and differ by 164 SNPs. A different color is used to represent each *Brucella* species. Dotted red lines denote the 3 *B. neotomae* isolates, which overlap at the tip of the branch because of the high identity among them.](16-2018-F2){#F2}

Analysis of 23 previously reported genomic islands or anomalous genomic loci ([@R14]) was performed for both bneohCR genomes. For this analysis, a "genomic-island pseudo-molecule" was constructed by concatenation of 23 genomic regions obtained from different *Brucella* genomes. BLAST (<https://github.com/sanger-pathogens/Farm_blast>) comparison of this pseudo-molecule and the bneohCR draft genomes, generated by assembly with Velvet ([@R15]), showed that the genomic loci known as 26.5 kb, 12 kb, and GI-6 that are absent in *B. neotomae* ([@R14]) are also absent in the queried genomes.

Conclusions
===========

This report of *B. neotomae* as a cause of zoonotic disease raises questions about possible underrepresentation of reported cases. This study also has implications for brucellosis diagnosis. Specifically, the differences among *B. neotomae* and the other *Brucella* species at the biochemical level are subtle. The major difference between *B. neotomae* and *B. abortus*, the main cause of human brucellosis in Costa Rica, is the presence of oxidase activity in *B. abortus*, which is assessed subjectively ([@R7],[@R8]). Because *B. neotomae* has not, until now, been considered zoonotic, some cases of brucellosis reported as being caused by atypical zoonotic classical *Brucella* might have been misdiagnosed cases of *B. neotomae* infection. The introduction of whole-genome sequencing into the clinical field will thus improve diagnosis.

A lack of epidemiologic information with regard to the 2 patients reported here precluded the investigation of exposure or contact with hosts known to harbor *B. neotomae*. Further studies are needed to establish which animals may act as reservoirs for *B. neotomae* in Costa Rica.

In summary, *B. neotomae* should be considered a zoonosis risk for infection in humans. Incorporation of molecular techniques for diagnosis will help resolve the *Brucella* genus homogeneity obtained when only biochemical assays are used.

###### Technical Appendix

Protein mass values of *Brucella* reference strains and bneohCR2, and general information and accession numbers of the genomes included in the phylogenetic analysis.
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